Evaluation (Safety and Efficacy) of Treatment With Insulin Glargine and Glimepiride in Patients With Type 2 Diabetes Before, During and After the Period of Fasting in Ramadan.
Phase of Trial: Phase IV
Latest Information Update: 07 Jun 2011
At a glance
- Drugs Glimepiride; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Sponsors Sanofi
- 31 Aug 2018 Biomarkers information updated
- 07 Jun 2011 Actual end date (Feb 2006) added as reported by ClinicalTrials.gov.
- 14 Sep 2006 New trial record.